Literature DB >> 22526932

[Staging of rectal cancer].

C T Germer1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22526932     DOI： 10.1007/s00104-011-2201-x

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  10 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

Authors:  W Schmiegel; C Pox; A Reinacher-Schick; G Adler; D Arnold; W Fleig; U R Fölsch; P Frühmorgen; U Graeven; V Heinemann; W Hohenberger; A Holstege; T Junginger; I Kopp; T Kühlbacher; R Porschen; P Propping; J-F Riemann; C Rödel; R Sauer; T Sauerbruch; W Schmitt; H-J Schmoll; T Seufferlein; M Zeitz; H-K Selbmann
Journal:  Z Gastroenterol       Date:  2010-01-13       Impact factor: 2.000

3.  Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.

Authors:  E Urso; S Serpentini; S Pucciarelli; G L De Salvo; M L Friso; G Fabris; S Lonardi; B Ferraro; A Bruttocao; C Aschele; D Nitti
Journal:  Eur J Surg Oncol       Date:  2006-07-26       Impact factor: 4.424

4.  Endorectal ultrasound in rectal carcinoma--do the literature results really correspond to the realities of routine clinical care?

Authors:  F Marusch; H Ptok; M Sahm; U Schmidt; K Ridwelski; I Gastinger; H Lippert
Journal:  Endoscopy       Date:  2011-01-13       Impact factor: 10.093

Review 5.  Nonoperative approaches to rectal cancer: a critical evaluation.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Guilherme P São Julião; Igor Proscurshim; Joaquim Gama-Rodrigues
Journal:  Semin Radiat Oncol       Date:  2011-07       Impact factor: 5.934

6.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.

Authors:  Willem van Gijn; Corrie A M Marijnen; Iris D Nagtegaal; Elma Meershoek-Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm J T Rutten; Lars Påhlman; Bengt Glimelius; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2011-05-17       Impact factor: 41.316

7.  Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.

Authors:  Monique Maas; Patty J Nelemans; Vincenzo Valentini; Prajnan Das; Claus Rödel; Li-Jen Kuo; Felipe A Calvo; Julio García-Aguilar; Rob Glynne-Jones; Karin Haustermans; Mohammed Mohiuddin; Salvatore Pucciarelli; William Small; Javier Suárez; George Theodoropoulos; Sebastiano Biondo; Regina G H Beets-Tan; Geerard L Beets
Journal:  Lancet Oncol       Date:  2010-08-06       Impact factor: 41.316

8.  Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study.

Authors:  Fiona G M Taylor; Philip Quirke; Richard J Heald; Brendan Moran; Lennart Blomqvist; Ian Swift; David J Sebag-Montefiore; Paris Tekkis; Gina Brown
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

Review 9.  [Current imaging for rectal cancer].

Authors:  M S Juchems; A J Aschoff
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

10.  Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgery.

Authors:  Alexis Ulrich; Jürgen Weitz; Matthias Slodczyk; Moritz Koch; Dirk Jaeger; Marc Münter; Markus W Büchler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-21       Impact factor: 7.038
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.